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RESEARCH ARTICLE
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Abstract
Bovine tuberculosis is a zoonotic disease of global public health concern. Development of
diagnostic tools to improve test accuracy and efficiency in domestic livestock and enable
surveillance of wildlife reservoirs would improve disease management and eradication
efforts. Use of volatile organic compound analysis in breath and fecal samples is being
developed and optimized as a means to detect disease in humans and animals. In this study
we demonstrate that VOCs present in fecal samples can be used to discriminate between
non-vaccinated and BCG-vaccinated cattle prior to and after Mycobacterium bovis
challenge.
Introduction
Bovine tuberculosis (bTB), a zoonotic disease affecting international public health, agricul-
tural, wildlife, and trade [1, 2], is caused by Mycobacterium bovis. The etiological agent respon-
sible for most of the 9.6 million annual human tuberculosis cases [3] is M. tuberculosis;
however, approximately 30% of cases may be caused by M. bovis infection, especially in devel-
oping countries [4] where prevalences of livestock bTB may approach 10–14% [5–8]. The eco-
nomic costs associated with bTB are significant; from 2008–2009 estimated economic losses
globally and in the United States (US) were $3 billion and $40 million, respectively [2].
The US federal bTB eradication program has been successful in decreasing the prevalence
of bTB to approximately 0.0006% [2]; however, outbreaks in domestic cattle (Bos tarus) and
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captive and farmed cervids continue to occur. Importation or migration of infected animals
from other countries and endemically infected feral swine (Sus scrofa; Molokai Island, Hawaii)
and white-tailed deer (Odocoileus virginianus; Michigan and Indiana) serve as sources for rein-
troduction of the disease to domestic livestock [9–15]. Antemortem surveillance tests used for
domestic cattle include the caudal fold (CFT) and comparative cervical (CCT) skin tests, and
the interferon gamma (IFN-γ) release assay (IGRA; Bovigam, Prionics Ag, Schlieren-Zurich,
Switzerland). The sensitivity (SN) and specificity (SP) of these tests are reasonable, but all are
labor intensive and lack efficient time to results [1, 7]. Other in vitro assays have limitations
associated with accuracy and execution that restrict their use in ante-mortem surveillance [7].
Development of an ante-mortem disease monitoring system capable of detecting M. bovis
infection in cattle, cervids such as white-tailed deer, feral swine, and other wildlife species
would improve bTB surveillance by decreasing or eliminating animal handling events, and
remove the requirement for specialized training. This system should be highly repeatable, cost
efficient, highly sensitive and specific, and provide rapid and early detection of diseased indi-
viduals. Evaluation of volatile organic compounds (VOCs) present in breath, biofluids such as
urine and blood, and feces have been conducted in an effort to develop a diagnostic modality
for identifying disease (including tuberculosis) in humans [16–27]. In cattle, VOC analysis of
breath samples has been explored as a method for diagnosis of bovine respiratory disease [28],
brucellosis [29], bTB [30–32], Johne’s disease [29, 33], and ketoacidosis [34, 35]. Fecal VOC
analysis has been used experimentally to identify goats [33, 36] and cattle [37] infected with
Mycobacterium avium paratuberculosis (MAP; Johne’s disease).
In previous work we found that fecal headspace VOCs could be used discriminate between
non-vaccinated and Bacillus Calmette-Guerin (BCG) vaccinated white-tailed deer prior to and
after virulent M. bovis challenge with a high degree of SN and SP [38]. The goal of this study
was to demonstrate that fecal headspace VOCs could be used to differentiate between non-vac-
cinated and BCG-vaccinated cattle prior to and post- virulent M. bovis challenge. Based upon
the results of our analysis, we were successful in achieving this goal. The results of this study,
combined with our previous studies [30, 32, 38, 39] provide evidence that breath and fecal
VOC analysis have merit for disease surveillance in ruminant species. Our work provides data
that adds to existing studies in this area, and encourages future development of VOC analyses
for disease diagnosis in human and veterinary medical fields.
Animals, materials and methods
Ethics statement
All studies were approved by the Institutional Biosafety and Animal Care and Use Commit-
tees (IACUC) of the of the United States Department of Agriculture (USDA), Agricultural
Research Service (ARS), National Animal Disease Center (NADC), Ames, Iowa, USA (Ani-
mal Care and Use Protocol (ACUP) 2688); the USDA, Animal and Plant Health Inspection
Service (APHIS), National Wildlife Research Center (NWRC), Fort Collins, Colorado, USA
(Protocol QA-2262); and Iowa State University (ISU), Ames, Iowa, USA (IACUC 4-14-
7787-B), and were performed within the conditions of the Animal Welfare Act. All animals
were housed in appropriate biological containment facilities at NADC under the direct
supervision of the institutional clinical veterinarian. Animals were monitored twice daily for
overall body condition and well-being, and for any signs of signs of suffering and distress.
Strict biosafety protocols were followed to protect personnel from exposure to M. bovis,
including BSL-3 containment upon initiation of M. bovis challenge in animal rooms and
standard BSL-3 and BSL-2 laboratory practices for handling M. bovis cultures and samples
from M. bovis-infected animals.
Fecal volatile organic compound analysis to detect Mycobacterium bovis
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Animals and Mycobacterium bovis challenge
One to two day old Holstein bull calves (n = 20) were acquired from a M. bovis-free, M. avium
paratuberculosis-monitored herd, and placed into a NADC BSL-3 agricultural facility for the
duration of the study. Cattle were housed under environmental conditions appropriate for
normal physiological thermoregulation; in separate biocontainment rooms; with no exchange
of air, food, or water occurring between rooms. Diet consisted of alfalfa hay cubes and a com-
mercial pelleted ration provided twice daily, and water ad libitum. All calves were castrated
at 42–43 days of age (S1 Table). One individual in the BCG treatment group was humanely
euthanized prior to the completion of the study due to a non-study related health issue,
decreasing the number of individuals in that cohort (n = 9). Given the low dose challenge and
relatively short duration of the study, cattle did not develop clinical signs of bTB (cough, dys-
pnea, anorexia, weight loss) necessitating palliative therapy.
Mycobacterium bovis strain 10–7428_CO_Dairy_10-A (M. bovis strain 10–7428; USDA,
APHIS designation) was used for the challenge inoculum. The inoculum was prepared using
standard procedures in Middlebrook 7H9 liquid media (Becton Dickinson, Franklin Lakes,
NJ, US) as described by Larsen et al 2005 [40]. Enumeration of M. bovis challenge inoculum
was performed as previously described [41]. Calves were challenged by aerosol with M. bovis
using the method described by Palmer et al 2002 [41] at 120–121 days of age.
Diagnostic tests performed
Blood samples were collected from all calves seven days prior to vaccination, 20, 42, and 56
days post-vaccination, nine, 16, and 70 days post-challenge for in vitro evaluation of cellular
immune responses (CMI) to mycobacterial antigens. The CCT was performed according to
USDA, APHIS circular 91-45-01 guidelines [42] on all animals 104 days post-challenge (7 days
prior to necropsy). Balanced purified protein derivatives (PPDs) were obtained from the Bru-
cella and Mycobacterial Reagents Section of The USDA National Veterinary Services Labora-
tory, Ames, IA. Calves were administered 0.1 mL (100 μg) M. bovis PPD (PPDb) and 0.1 mL
(40 μg) M. avium PPD (PPDa) intradermally at separate clipped sites on the side of the neck.
Calves were humanely euthanized by intravenous administration of sodium pentobarbital 111
days post-challenge. Necropsy procedures, and gross and microscopic assessment of lesions
were performed as described in Palmer et al 2002 [41]. When microscopic lesions consistent
with bTB were identified, adjacent sections were stained by the Ziehl Neelsen technique to
visualize acid-fast bacilli. Mediastinal, tracheobronchial, medial retropharyngeal, and prefe-
moral lymph nodes and lungs were sampled for M. bovis isolation and identification as previ-
ously described [43]. Qualitative assessment of mycobacterial colonization was performed
using standard mycobacterial culture techniques [44] with Middlebrook 7H11 selective agar
plates (Becton Dickinson, Franklin Lakes, NJ, USA) incubated for 8 weeks at 37˚C. Confirma-
tion of colonies was performed as previously described [45] using IS6110 real time PCR
(RT-PCR).
Fecal sample collection
Fecal samples were collected per rectum from all calves one day prior to virulent M. bovis chal-
lenge and prior to necropsy. Samples were placed in air-tight 50 mL conical centrifuge tubes,
and stored on ice until transport to the NADC Tuberculosis Research Laboratory. Fecal sample
processing was performed in a Biosafety Class II cabinet (BSC-II). A 1.5 gm fecal aliquot was
removed from each sample using a 3.0 mL hypodermic syringe modified by removing the
apex of the syringe barrel. Feces were deposited in the bottom of a clean 20 mL amber glass
vial (Wheaton, Millville, NJ, USA) and the vial sealed with an air-tight lid containing a PTFE-
Fecal volatile organic compound analysis to detect Mycobacterium bovis
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lined silicone septum. The outer surface of each vial was decontaminated with tuberculocidal
disinfectant (Wexcide, Wexford Labs, Kirkwood, MO USA) and transported in a sealed trans-
fer container to the ISU Atmospheric Air Quality Laboratory for analysis.
Sample preparation for GC/MS analysis and GC/MS conditions
Pre-concentration of VOCs was performed using a 2 cm 50/30 μm DVB/Carboxen/PDMS
(57348-U, Supelco, Bellefonte, PA, USA) SPME fiber mounted in a CTC Combi PAL™ LEAP
GC autosampler (LEAP Technologies, part of Trajan Family, Inc., Carrboro, NC, USA)
equipped with a heated agitator (37˚C, 250 rpm agitation). Each sample vial was transferred to
the heated agitator, thermally equilibrated for 10 minutes, followed by SPME insertion and
headspace exposure for 45 min. The SPME fiber was then transferred and inserted into the GC
inlet and desorbed with the GC inlet configured in splitless mode at 250˚C using helium (He)
carrier gas (99.995% purity). Multi-Dimensional Gas Chromatography–Mass Spectrometry
(MDGC-MS) analysis was performed on an Agilent 6890 GC with a restrictor guard column,
non-polar capillary column (BP-5, 30.0 m x 530 μm inner diameter x 0.5 μm thickness, SGE,
Austin, TX, USA) and polar capillary column (BP-20, 30.0 m x 530 μm inner diameter x
0.5 μm thickness, SGE, Austin, TX, USA) connected in series. Sample flow was split 3:1 via
open split interface to an olfactometry port (not used in this research) and mass spectrometer,
respectively. Flow to the mass spectrometer was determined by the fixed restrictor column
inner diameter and excess effluent was directed to the olfactory sniff port. The carrier gas was
set to constant pressure of 5.7 psi at the midpoint (connection point of the non-polar and
polar column). Oven temperature was programmed as follows: 40˚C for 3.00 minutes, ramped
to 240˚C at a rate of 7˚C/min, and held for 8.43 min. Transfer line to the MS was set at 280˚C,
and heated zones were 150˚C for the single quadrupole and 230˚C for the source. The MS was
operated in electron ionization (EI) mode, with the electron energy set to 70eV, scanning from
m/z 34.0–350.0.
Data analysis
Files containing GC-MS data for two BCG-vaccinated animals were corrupted, resulting in
exclusion of these animals from our analysis. Remaining BCG-vaccinated animals (n = 7) were
placed into two samples groups based on post-challenge responses to challenge (Table 1). To
keep sample group sizes similar for analyses, four non-vaccinated animals were randomly
selected for our analyses. Final sample group designations included BCG-vaccinated virulent
M. bovis positive calves (BCGprePOS, BCGpostPOS; n = 3); BCG-vaccinated calves with no
evidence of virulent M. bovis infection (BCGpreNEG, BCGpostNEG; n—4); and non-vacci-
nated virulent M. bovis positive calves (NVpre, NVpost; n = 4).
Baseline-corrected chromatograms were analyzed using the multi-group comparison fea-
ture in XCMS Online [46, 47] (www.xcmsonline.scripps.edu) to identify peak ion abundances
that differed across sample groups. All remaining statistical analysis were performed using sta-
tistical packages available in “R” [48–50]. A principal component analysis (PCA) was per-
formed on the statistically significant ions (α = 0.05, 1.5 fold difference), and the PC scores
proportion of variance and cumulative proportion of variance were used to develop five class
linear discriminant analysis (LDA) classification models. Training and test datasets containing
70% and 30% of the data were used to produce predicted classifications for each sample, and
the results were compared to actual sample group assignment. Misclassification rates were
calculated to evaluate the feasibility of using statistically significant ions to discriminate
between the sample groups. The number of true positive (infected calves; NVpost, BCGpost-
POS); true negative (pre-challenge treatment groups and the post-challenge non-infected
Fecal volatile organic compound analysis to detect Mycobacterium bovis
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BCG-vaccinated calves; NVpre, BCGpre, BCGpostNEG); false positive (true negative calves
incorrectly classified as infected), and false negative (true positives incorrectly classified as
non-infected) animals were summed. Sensitivity was calculated as the total number of true
positives divided by the sum of the true positives plus false negatives, and SP was calculated as
the total number of true negative samples divided by the sum of the true negatives plus false
positives [51]. An agglomerative hierarchical cluster analysis using Ward’s method was per-
formed to further assess use of ion data as a means to discriminate between individual and
grouped samples, and to test the robustness of the PCA and LDA classification models.
Statistically significant ion intensities identified by XCMS Online were retention time
matched with total ion chromatographic (TIC) peaks using Agilent Mass Hunter software
(Agilent Technologies, Santa Clara, CA, USA), and associated peak areas were incorporated
into PCA and LDA analyses to assess the feasibility of using the identified peaks to discrimi-
nate between sample groups. Group mean peaks areas were calculated for each peak, and
between groups mean peak area fold differences > = 3.0 and biological relevance were used to
identify a suite of peaks that best allowed discrimination between the sample groups. This
suite of selected peaks was reanalyzed to determine if a minimum number of peaks might be
used to discriminate between the sample groups, and whether any peaks might function as bio-
markers associated with disease and/or vaccination status. Peaks meeting a minimum spectral
match probability> = 65% were tentatively identified using the National Institute of Standards
and Technology (NIST) W8N08 database (www.nist.gov), the Kyoto Encyclopedia of Genes
Table 1. Sample group designation and diagnostic test results for calves.
Animal ID Post-challenge Diagnostic Test Results
Cfu/gm TBLN virulent
M. bovis1
Gross lesion noted
in lung
Gross lesion noted in
lymph node(s)
Histopathology ΔPPDb2 RT-PCR Culture
Non-Vaccinated virulent M. bovis positive calves
NVpre5 NVpost5 2989 + + + 28 + +
NVpre88 NVpost88 1600 + + + 62.5 + +
NVpre91 NVpost91 545 + + + 64.5 + +
NVpre95 NVpost95 82796 + + + 43.5 + +
BCG-vaccinated virulent M. bovis positive calves
BCGprePOS8
BCGpostPOS8
0 - + + 54 + +
BCGprePOS84
BCGpostPOS84
1058 - - + 33.5 + +
BCGprePOS86
BCGpostPOS86
0 - - + 59 + +
BCG-vaccinated virulent M. bovis negative calves
BCGpre6 BCGpost6 0 - - - 9.5 - -
BCGpre76 BCGpost76 0 - - - 33.5 - -
BCGpre77 BCGpost77 0 - - - 16 - -
BCGpre85 BCGpost85 0 - - - 20.5 - -
1 Colony forming units M. bovis cultured per gram tracheobronchial lymph node
2 Change in response to PPDb pre- vs. post virulent M. bovis challenge
Paired fecal samples collected from non-vaccinated and BCG-vaccinated calves selected for gas chromatography–mass spectrometry (GC-MS) analysis
based on results of diagnostic testing, necropsy, and histopathological results. Samples were collected pre- and post- virulent M. bovis challenge. Each
paired sample is identified by vaccination status, pre- or post-challenge time-point, and infection status (example: non-vaccinated pre-challenge = NVpre;
BCG-vaccinated pre-challenge (BCGpre); non-vaccinated post-challenge (NVpost); BCG-vaccinated post-challenge not infected (BCGpostNEG); BCG-
vaccinated post-challenge infected (BCGpostPOS).
https://doi.org/10.1371/journal.pone.0179914.t001
Fecal volatile organic compound analysis to detect Mycobacterium bovis
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and Genomes database [52, 53], and the Human Metabolome Database [54, 55]. When multi-
ple compounds were tentatively identified at one retention time, all tentative compound iden-
tifications were considered based on the possibility of co-elution and likelihood that no
reference library contains all known compounds.
Results
Diagnostic tests
Over the course of the study, no differences in overall health or clinical disease severity were
observed among non-vaccinated or BCG-vaccinated calves prior to or after challenge with vir-
ulent M. bovis (excluding the BCG vaccinated animal euthanized prior to study completion).
Results of the CCT skin test and in vitro evaluation of cellular immune responses to mycobac-
terial antigens are published elsewhere [56]. Briefly, all calves were classified as reactors based
upon standard interpretation of the CCT skin test [42]. Mean responses of NVpost calves to
PPDb were significantly greater than responses observed in the BCGpostNEG and BCGpost-
POS calves (S1 Fig). Observed responses to PPDb were significantly greater than the responses
to PPDa (S2 Fig), and robust cell-mediated immune responses to mycobacterial antigens were
present all calves in all treatment groups [56]. Semi-quantitative scoring of gross lesions in the
lungs and lymph nodes (tracheobronchial and mediastinal; TBLN), histopathology, and
isolation and identification of mycobacterial isolates were performed at NADC (Table 1)
[56]. Gross lesions were noted in the lungs and tracheobronchial and mediastinal lymph
nodes of all NVpost calves. Gross lesions were noted in the TBLN of one post-challenge BCG-
vaccinated calf (BCGpostPOS8). Granulomas containing acid-fast bacteria were identified his-
tologically in the TBLN of all NVpost and BCGpostPOS calves. Calves in the NVpost and
BCGpostPOS sample groups were confirmed positive for virulent M. bovis by culture and
RT-PCR. There was no evidence of virulent M. bovis presence in BCGpostNEG calves.
Analysis of ion features
The analysis performed using XCMS Online identified 180 ions, with 105 ions meeting the cri-
teria for statistical significance (α = 0.05; fold change 1.5). Visualization of the characteristics
of the statistically significant ion features are presented as a cloud plot (S3 Fig) [57]. The ion
PCA classification model was developed using 76 of the 105 statistically significant ions.
Twenty-nine ions occurring at late retention times (> 34.0 min) attributed to baseline noise
were excluded from the analysis. Results are depicted in a three dimensional (3D) scatterplot
(Fig 1). Pre- and post-challenge samples groups are distinctly separate within the three dimen-
sional space. Separation is present between NVpre and all BCG-vaccinated (BCGprePOS,
BCGpreNEG) sample groups. NVpost, BCGpostPOS and BCGpostNEG sample groups are
distinctly separate as well.
Five class LDA classification models were constructed using two through six PC scores.
The model constructed using two PC scores resulted in correct classification of 95% of calves
(Table 2). All misclassifications consisted of NVpre calves incorrectly classified as BCGpre
calves (i.e., true negatives classed into a different true negative group) which did not adversely
affect effect SN:SP (100%; 100%). Classification models constructed using three through six
PC scores contained no misclassifications, and calculated SN:SPs of 100%:100%.
The ion cluster analysis shows initial pairing of individual calves within respective sample
groups. Subsequent progression places paired individuals into respective pre- and post- viru-
lent M. bovis challenge groups (Fig 2). The final clustering produces clear separation between
pre- and post-challenge sample groups. Inter-group discrimination is present between NVpre
and BCGpre animals. All BCGpreNEG and BCGprePOS samples are found within one cluster,
Fecal volatile organic compound analysis to detect Mycobacterium bovis
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indicating that these samples are similar prior to virulent M. bovis challenge. After challenge,
BCGpostNEG and BCGpostPOS samples are found within separate, but closely associated
clusters, indicating that while the presence of virulent M. bovis in BCGpostPOS animals has
induced some difference in those individuals, they still are similar. The location of all NVpost-
POS individuals into a distinct cluster indicates that lack of BCG-vaccination prior to chal-
lenge creates a strong inter-group variation.
Analysis of peak areas and compound identification. Ions identified as statistically sig-
nificant were GC column retention time matched to 23 chromatographic peaks. Ten peaks
were identified by single ion matches, while the remainder (n = 13) were matched to multiple
ions. Peak area data were visually inspected for biological relevance, and using these criteria,
eight peaks were excluded from consideration. Two additional peaks identified as silane-con-
taining compounds were removed because they were likely contaminants eluted from the GC
column or septa material, leaving 13 peaks available for further analysis and tentative com-
pound identification.
The peak area PCA classification analysis was reliably capable of discriminating between
the sample groups (Fig 3). Separation of pre- and post-challenge samples is present indicating
that exposure to virulent M. bovis induces distinct changes in all individuals regardless of vac-
cination status. Individuals within treatment groups cluster in close association indicating sim-
ilarity. BCGpreNEG and BCGprePOS animals cluster together indicating that there is little
difference between BCG-vaccinated individuals prior to virulent M. bovis challenge. The
Fig 1. Principal component analysis three dimensional scatterplot of 76 ions. Pre-challenge non-
vaccinated (NVpre) and BCG-vaccinated (BCGpreNEG; BCGprePOS) sample groups are indicated by green
and blue circles, respectively. Post-challenge virulent M. bovis positive non-vaccinated (NVpost) and BCG-
vaccinated (BCGpostPOS), and virulent M. bovis negative BCG-vaccinated (BCGpostNEG) sample groups
are indicated by red, orange, and purple circles, respectively. Pre- and post-challenge sample groups are
separate within the three dimensional space, indicating that pre-challenge and post-challenge calves are
different. Pre-challenge sample groups (NVpre; combined BCGprePOS, BCGpreNEG) are separate
indicating that these sample groups are distinctly different from each other. Post-challenge sample groups are
separate and distinct, indicating that these sample groups are different. Within each sample group, individual
samples appear closely associated with each other indicating that intra-group samples are similar to each
other.
https://doi.org/10.1371/journal.pone.0179914.g001
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BCGpre sample group and NVpre sample groups are separate. Post-challenge the BCGpost-
NEG and BCGpostPOS groups form separate clusters, indicating that the persistent presence
of virulent M. bovis in BCGpostPOS animals induces differences between these groups.
NVpost individuals form a separate cluster with the exception of one pre-challenge non-vacci-
nated animal (NVpost91).
LDA classification models were developed using two through four PCs. Models returning
the lowest misclassification rates were constructed using two and four PC scores (Table 3). No
misclassifications were observed, and corresponding SN:SP were 100%:100%, respectively.
The misclassification rate for the model constructed using three PC scores was 17%, with all
misclassified samples (100%) consisting of BCGpostPOS calves misclassified as BCGpostNEG
(false negative samples). The calculated SN:SP for this model were 83%:100%.
Table 2. Linear discriminant analysis classification of calves using statistically significant ions.
Number of Principal Components 2 3 4 5 6
Misclassification Rate (%) 5 0 0 0 0
Correct Classification Rate (%) 95 100 100 100 100
Misclassification
• False Negative (%) 0 0 0 0 0
 Nvpost misclassified Nvpre 0 0 0 0 0
 Nvpost misclassified BCGpre 0 0 0 0 0
 Nvpost misclassified BCGpostNEG 0 0 0 0 0
 BCGpostPOS misclassified Nvpre 0 0 0 0 0
 BCGpostPOS misclassified BCGpre 0 0 0 0 0
 BCGpostPOS misclassified BCGpostNEG 0 0 0 0 0
• False Positive (%) 0 0 0 0 0
 Nvpre misclassified Nvpost 0 0 0 0 0
 Nvpre misclassified BCGpost POS 0 0 0 0 0
 BCGpre misclassified Nvpost 0 0 0 0 0
 BCGpre misclassified BCGpostPOS 0 0 0 0 0
 BCGpostNEG misclassified BCGpostPOS 0 0 0 0 0
 BCGpostNEG misclassified NVpost 0 0 0 0 0
• True Negative (%) 0 0 0 0 0
 Nvpre misclassified BCGpre 100 0 0 0 0
 Nvpre misclassified BCGpostNEG 0 0 0 0 0
 BCGpre misclassified Nvpre 0 0 0 0 0
 BCGpre misclassified BCGpostNEG 0 0 0 0 0
 BCGpostNEG misclassified Nvpre 0 0 0 0 0
 BCGpostNEG misclassified BCGpre 0 0 0 0 0
• True Positive (%) 0 0 0 0 0
 Nvpost misclassified BCGpostPOS 0 0 0 0 0
 BCGpostPOS misclassified Nvpost 0 0 0 0 0
Sensitivity (%) 100 100 100 100 100
Specificity (%) 100 100 100 100 100
Five class models were constructed using two through six principal component analysis (PCA) dimensional scores. Models resulting in optimal
misclassifications (0%), and SN:SP (100%:100%) were constructed using three through six PC scores. The model constructed using two PC scores
returned the highest misclassification rate (5%); however, all misclassifications (100%) consisted of NVpre (true negative) animals misclassified as
BCGpreNEG animals (true negatives), which did not affect the SN:SP (100%:100%).
https://doi.org/10.1371/journal.pone.0179914.t002
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The peak area cluster analysis shows pairing of individuals within treatment group designa-
tion (Fig 4). As the hierarchical model progresses, two BCGpostPOS animals (BCGpostPOS84,
BCGpostPOS86) group among the BCGpostNEG animals. The remaining BCGpostPOS ani-
mal occupies a separate space in the tree. In the next hierarchical progression, three groups are
identified. NVpost animals form a distinct group; all pre-challenge animals (NVpre; BCGpre)
fall within a second group; and all post-challenge BCG-vaccinated animals form a third group.
The final two groupings consist of one cluster containing all NVpost animals, and another
containing all the other animals, indicating that the NVpost cattle are truly unique compared
to the other sampled populations. Within the group containing all other treatment groups,
NVpre and BCGpre sample groups are distinct from the BCGpostNEG and BCGpostPOS
groups. The two misclassified BCGpostPOS animals (BCGpostPOS84, BCGpostPOS86) are
identical to those identified in the ion cluster analysis.
Tentative identifications of peaks and associated information are summarized in Table 4.
Briefly, compounds tentatively identified using a> = 65% probability match in the
NISTW8N08 library include an alcohol; an aldehyde; an alkane; an imine; an indole; one
ketone; a pyridine derivative; and a thioether. Five peaks could not be identified using this
database. Compounds tentatively identified using the KEGG and HMDB databases that dif-
fered from NIST included an organosulfur; an amino acid; an alcohol; a salt of chloric acid; a
fatty acid; and a dicarboxylic acid. Five peaks were not identified by KEGG or HMDB. Three
compounds could not be identified by any of the databases used.
Fold changes in mean peak area between treatment groups were calculated to identify peaks
with greatest potential to perform dependent (pre- vs. post-challenge) and independent (vacci-
nation and infection status) groups comparisons (S2 Table). A mean fold difference > = 3.0
Fig 2. Agglomerative hierarchical cluster analysis constructed using 76 ions. Initial pairing of
individuals of respective sample groups is present. Progression through the hierarchy places paired
individuals into respective sample groups. The final separation places each individual its respective pre- or
post-challenge group. Clear separation of pre- and post-challenge sample groups is observed. Clear
separation of NVpre and BCGpre individuals indicates that these animals are distinctly different. All
BCGpreNEG and BCGprePOS samples are within one cluster, indicating similarity prior to virulent M. bovis
challenge. Post-challenge BCGpostNEG and BCGpostPOS samples within separate, but closely associated
clusters, indicates that while difference among those individuals is present, they still are similar. All
NVpostPOS individuals are found in a distinct cluster indicating a strong inter-group variation.
https://doi.org/10.1371/journal.pone.0179914.g002
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was used to identify peaks that best allowed inter- and intra-groups discrimination. The results
of this comparison demonstrate that while specific fecal VOC biomarkers indicative of vaccina-
tion and/or disease status were not identified, differentiation between groups is still possible
using suites of VOCs (Table 5). In the NVpre vs. NVpost comparison, twelve peaks had mean
peak area fold differences meeting our selection criteria, with six peaks (2–4, 7, 11–12) having
the greatest differences. For the BCGpreNEG vs. BCGpostNEG comparison, 10 peaks were
identified, with 7 peaks (1–5, 9, 10) providing best discrimination. Six peaks (1–5 and 10) out of
eleven provide best differentiation between BCGprePOS and BCGpostPOS animals. NVpre
and BCGpre animals are discriminated by one peak (peak 7). For the NVpre vs. BCGpostNEG
groups comparison a suite of 11 peaks (1–10, 13) met our selection criteria, and four peaks (1–
3, 7) had the greatest mean fold differences. Four of 11 peaks (1–3 and 7) allow best discrimina-
tion between NVpre and BCGpostPOS samples. Discrimination between NVpost and BCGpre
animals is best achieved using five (2–4, 11, 12) of 11 peaks. Four (peaks 8, 10–12) of eight
peaks are best capable of discriminating between NVpost and BCGpostNEG animals. A suite of
seven VOCs was identified in the NVpost vs. BCGpostPOS comparison, with two peaks (8, 12)
having the greatest mean fold difference. Two peaks (peaks 11 and 9) comprise the suite of
VOCs best capable of discriminating between BCGpostNEG and BCGpostPOS animals. While
we were unable to identify a specific biomarker indicative of vaccination status or presence of
virulent M. bovis infection, the results of our analysis do demonstrate the merit in evaluating
multiple VOCs as a means of identifying animal cohorts.
Fig 3. Three dimensional principal components analysis scatterplot of 13 peaks. All BCG-vaccinated
individuals are located within one cluster prior to challenge indicating that there is little difference present
among vaccinated individuals at this time-point. NVpre individuals are located in a cluster distinctly separate
from BCGpre individuals. Pre- and post-challenge sample groups are separate, indicating that differences
exist between pre-and post-challenge individuals. Post-challenge, two BCG sample groups are present, and
are distinctly separate from the NVpost sample group. Individuals within treatment groups cluster in close
association indicating similarity among individuals with respect to vaccination and/or persistence of virulent M.
bovis.
https://doi.org/10.1371/journal.pone.0179914.g003
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Potential sources, and cellular, biological or metabolic functions associated with each tenta-
tively identified compound were explored using KEGG, HMDB, and literature searches [32,
38, 53–55, 58–77] (Tables 6 and 7). Extensive metabolic information relative to M. bovis is not
published; therefore, we referred to information published for M. tuberculosis when necessary.
Eight tentatively identified compounds could be associated with mammalian systems. Another
eight compounds could be associated with microbial cellular function. Seven compounds
appear associated with mycobacterial metabolism, seven have been identified in cattle, four
appear to be involved in non-mycobacterial microbial metabolism, and two are associated
with immunological function. Overlap occurs among multiple compounds. For example, cit-
rulline is associated with macrophage metabolism and function; is produced as by-product of
the urea cycle, and is utilized by rumen microflora to convert urea to ammonia.
Table 3. Five way linear discriminant analysis classification of calves using 13 peaks.
Number of Principal Components 2 3 4
Misclassification Rate (%) 0 17 0
Correct Classification Rate (%) 100 83 100
Misclassification
• False Negative (%) 0 0 0
 Nvpost misclassified Nvpre 0 0 0
 Nvpost misclassified BCGpre 0 0 0
 Nvpost misclassified BCGpostNEG 0 0 0
 BCGpostPOS misclassified Nvpre 0 0 0
 BCGpostPOS misclassified BCGpre 0 0 0
 BCGpostPOS misclassified BCGpostNEG 0 100 0
• False Positive (%) 0 0 0
 Nvpre misclassified Nvpost 0 0 0
 Nvpre misclassified BCGpost POS 0 0 0
 BCGpre misclassified Nvpost 0 0 0
 BCGpre misclassified BCGpostPOS 0 0 0
 BCGpostNEG misclassified BCGpostPOS 0 0 0
 BCGpostNEG misclassified NVpost 0 0 0
• True Negative (%) 0 0 0
 Nvpre misclassified BCGpre 0 0 0
 Nvpre misclassified BCGpostNEG 0 0 0
 BCGpre misclassified Nvpre 0 0 0
 BCGpre misclassified BCGpostNEG 0 0 0
 BCGpostNEG misclassified Nvpre 0 0 0
 BCGpostNEG misclassified BCGpre 0 0 0
• True Positive (%) 0 0 0
 Nvpost misclassified BCGpostPOS 0 0 0
 BCGpostPOS misclassified Nvpost 0 0 0
Sensitivity (%) 100 83 100
Specificity (%) 100 100 100
Models resulting in lowest misclassification (0%) and optimal SN:SP (100%:100%) were constructed using
two and four PC scores. The model developed using three PC scores returned a misclassification rate of
83%. All misclassifications occurring (100%) in this model were false negatives (BCGpostPOS animals
misclassified BCGpostNEG).
https://doi.org/10.1371/journal.pone.0179914.t003
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Discussion
We were successful in discriminating between sample groups using statistically significant ion
data extracted from our raw data by XCMS Online. The PCA performed on these data resulted
in correct classification of all animals to their respective dependent (pre- and post- virulent M.
bovis challenge) and independent (vaccination and infection) groups. The LDA classification
models resulted in correct classification rates of 95–100% (0–5% misclassification). The cluster
analysis misclassed two BCGpostPOS animals as BCGpostNEG (false negatives). The best use
of the ion data was to evaluate the raw data in a preliminary format. For example, in this study,
the number of statistically significant ions associated with a specific peak inconsistently ranged
from a single ion to six ions, potentially biasing the analysis toward over or under representa-
tion of certain chromatographic peaks. Because ion count data do not reflect peak area, ion
intensity does not equate to differences in VOCs between individuals or treatment groups.
The intensity of a single ion may not represent the parent ion for a compound, and may result
from the ionization of multiple co-eluting compounds that share a common ionization frag-
ment. Finally, relative to the intended purpose of our research (assessment of host-pathogen
interactions), associated peaks need to be biologically logical in occurrence. This cannot be
ascertained using ion data.
The results generated by the peak area classification models are epidemiologically accept-
able. The calculated SN:SP of our optimal LDA classification models were 100%:100%, and
83%:100% for the model that performed poorly. In comparison, the SN:SP of the CFT, com-
parative CCT, and the IFN-ɣ assay have been reported to range from 68–96.8%:96–98%; 55.1–
93.5%:88.8–100% [2]; and 73–100%:87.7–99.2% [78], respectively. These results could be ade-
quately visualized in the PCA scatterplot. The cluster analysis misclassified two BCGpostPOS
animals as BCGpostNEG (false negatives). An advantage of the cluster analysis was its ability
to independently group data, eliminating potential selection bias on the part of the researcher,
unlike LDA which requires that the groups be defined prior to analysis. As such, we found the
cluster analysis a helpful tool to evaluate the robustness of our other analyses.
Fig 4. Agglomerative hierarchical cluster analysis dendrogram constructed using 13 peaks. Initial
pairings resulted in grouping of like samples. In the next hierarchical grouping, three NVpre samples
(NVpre88, 91 and 95) appear more closely associated with the BCGpre sample group than NVpre5, and two
BCGpostPOS (BCGpostPOS4 and 8) samples group with the BCGpostNEG samples. The final hierarchical
division identifies the NVpost samples as a distinct group separate from the grouped pre-challenge samples,
and the post-challenge BCG-vaccinated samples.
https://doi.org/10.1371/journal.pone.0179914.g004
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Table 4. Tentative compound identification of chromatographic peaks.
Peak Retention
Time
Tentative Compound Identification Database Identification
Number
Compound Class
Significant Ions
1 3.32 Dimethyl sulfide NIST W8N08 Thioether
62(999) 47(953) 45(408) 46(361) 61(333) HMDB02303
KEGG00580
3-methylthiophene HMDB33119 Thiophene
97(999) 98(530) 45(174) 53(88) 39(81)
2 15.60 Benzaldehyde NIST W8N08 Aldehyde
77(999) 106(935) 105(889) 51(495) 50
(296)
KEGG 00261
HMDB0611
Dimethyl sulfone (methylsulfonylmethane,
MSM)
KEGG11142 Organosulfur (sulfone)
79(999) 15(830) 94(477) 81(49) 43(45) HMDB04983
3 16.02 Unknown
4 18.64 Methoxy-phenyl-oxime NIST W8N08 Imine
133(999) 151(649) 135(262) 73(167) 42
(165)
5 18.81 2-Methylpyridine (2-picoline) NIST W8N08 Pyridine derivative
93(999) 66(520) 92(288) 65(212) 78(206)
6 18.94 Citrulline KEGGC00327 Amino acid
69(999) 43(663) 56(638) 30(570) 28(459) HMDB00904
7 19.14 Unknown
8 25.31 Unknown
9 28.19 2-dodecanone NISTW8N08 Ketone
58(999) 43(752) 59(308) 71(289) 49(169) HMDB31019
2-chloro-1-propanol HMDB31335 Alcohol
31(999) 58(270) 27(177) 29(151) 62(132)
10 28.61 Chlorate KEGG01485 Inorganic non-metallic compounds containing a chlorate
as the largest oxoanionHMDB02036
11 28.68 1H-Indole NISTW8N08 Indole
HMDB00738
KEGG00463
12 29.44 2, 6, 10, 14-tetramethylhexadecane
(phytane)
NIST W8N08 Diterpenoid alkane
57(999) 71(712) 43(612) 85(349) 41(313)
5-hydroxy-lysine KEGG16741 Fatty acyl (amino acid derivative
70(999) 82(830) 43(684) 42(473) 56(469) HMDB06827
13 30.13 3, 7, 11, 15-tetramethyl-2-hexadecene1-ol
(phytol)
NISTW8N08 Diterpene alcohol
71(999) 43(361) 57(333) 55(299) 69(278) HMDB02019
KEGGC01389
Succinic acid (butanedoic acid KEGG00042 Dicarboxylic acid and derivative
55(999) 45(842) 74(753) 27(636) 100
(606)
HMDB00254
Chromatographic peaks were tentatively identified using three databases. Statistically significant ions identified by XCMS were included in identification of
compounds. The first five significant ion fragments as identified by compound matching are noted for reference.
https://doi.org/10.1371/journal.pone.0179914.t004
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We were successful in identifying associations between VOCs and vaccination status and/
or the presence of M. bovis infection. While individual VOCs did not appear to be exclusively
associated with sample cohorts, use of inter- and intra-group mean peak area fold differences
did identify suites of VOCs that allowed discrimination between independent and dependent
treatment groups. An analogy would be use of a blood chemistry analysis to assess the overall
function of all of an animal’s health, followed by evaluation of specific suites of individual
blood chemistries to assess renal, hepatic or pancreatic function.
These findings may infer that the changes noted are associated with host immunological
function; however, given that the BCG-vaccine is comprised of attenuated M. bovis that can
persist in host tissues [79], and the pathological persistence of virulent M. bovis in infected
hosts, it is plausible that some VOC changes reflect microbial and/or host metabolic, homeo-
static, or physiological processes. In this study, five of our tentatively identified compounds
have been associated with M. tuberculosis metabolism. Because reference libraries are not
exclusive or complete, and the likelihood that biological samples contain unknown com-
pounds. it is important to consider all potential chemical or metabolic matches [80]. Attempt-
ing to identify unknown compounds, or those with a low probability matches using a battery
of analytical standards is cost prohibitive and was not performed in this study.
We can state with confidence that our findings demonstrate it is possible to differentiate
between non- and BCG-vaccinated Holstein cattle before and after virulent M. bovis challenge
using fecal VOCs collected by methods similar but more refined than those used in a similar
study of white-tailed deer [38]. Two compounds identified by both studies (2-dodecanone,
2-methyl pyridine) shared the same trend in peak area fold difference between treatment
groups (cattle: NVpost > BCGpostPOS > BCGpostNEG > BCGpre >NVpre; white-tailed
deer: NVpost > BCGpostNEG > BCGpre > NVpre, there were no BCGpostPOS deer in this
study). A third compound (1H-indole) followed the described sample progression pattern in
white-tailed deer, and progressed by treatment group in cattle as NVpost > BCGpostPOS >
BCGpostNEG >NVpre = BCGpre, results that are similar and warrant further exploration.
None of the compounds found in the suite of breath VOCs used to discriminate between
healthy and virulent M. bovis infected cattle in our pilot study were identified here [32]. Several
Table 5. VOC suites allowing discrimination between sample groups.
Group Comparison Peaks
1 2 3 4 5 6 7 8 9 10 11 12 13 Total Peaks Identified Peaks with greatest mean fold difference
NVpre vs. NVpost 12 6
BCGpreNEG vs. BCGpostNEG 10 7
BCGprePOS vs. BCGpostPOS 11 6
NVpre vs. BCGpre 1 1
NVpre vs. BCGpostNEG 11 4
NVpre vs. BCGpostPOS 11 4
NVpost vs. BCGpre 10 5
NVpost vs. BCGpostNEG 8 4
NVpost vs. BCGpostPOS 7 2
BCGpostNEG vs. BCGpostPOS 2 2
Peak area mean fold differences were calculated for dependent (pre- vs. post-challenge) and independent (vaccination and infection status) treatment
group comparisons. Suites of peaks with fold differences meeting a minimum selection criteria (> = 3.0) were identified for each comparison. Peaks with
greatest mean fold differences are denoted in black. Peaks with lower mean fold differences are noted in gray. Peaks that do not meet the selection criteria
are denoted in white.
https://doi.org/10.1371/journal.pone.0179914.t005
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Table 6. Potential sources of peak compounds, and order of sample group mean peak areas.
Peak Tentative Compound
Identification
Tentative Associations [32, 38, 54, 55, 58–77]85, 86 Order of Mean Peak Area Fold Difference
1 Dimethyl sulfide • Found in culture headspace of M. bovis BCG
• Produced by bacterial metabolism of methanethiol
• M. tuberculosis and other mycobacteria possess the
mddA gene, which encodes a methyltransferase that
generates dimethyl sulfide via methylation of
methanethiol
BCGpostPOS = BCGpostNEG > NVpost >
NVpre = BCGpre
3-methylthiophene • Rumen byproduct
2 Benzaldehyde • Found in some plant material
• Found in feces of humans and animals infected with
Clostridium difficile or Campylobacter jejuni
NVpost > BGGpostPOS = BCGpostNEG > BCGpre >
NVpre
Dimethyl sulfone
(methylsulfonylmethane, MSM)
• Byproduct of intestinal bacterial metabolism
• Occurs in some plants
• Normal concentrations in human plasma and CSF
• VOC associated with rumen metabolism
3 Unknown BCGpostPOS = BCGpostNEG > NVpost >
BCGpre > NVpre
4 Methoxy-phenyl-oxime • Imines are common in nature.
Example: Vitamin B6 promotes the deamination of
amino acids via the formation of imines
NVpost > BCGpostPOS = BCGpostNEG > BCGpre >
NVpre
5 2-Methylpyridine (2-picoline) • May have some inhibitory function against
mycobacterial pantothenate synthetase
BCGpostPOS > BCGpostNEG = NVpost > BCGpre >
NVpre
6 Citrulline • Produced by ornithine and carbamoyl phosphate in a
central reaction of the urea cycle.
• Produced as a byproduct during nitric oxide
synthesis from arginine. Nitric oxide is synthesized
by macrophages from extracellular arginine during
early infection, generating citrulline as a byproduct. If
extracellular arginine is depleted, reverse synthesis
of arginine from citrulline sustains NO production via
arginosuccinate synthase. Macrophages lacking this
enzyme do not salvage citrulline and are ineffective
in controlling mycobacterial infection.
NVpre > BCGpre >
NVpost > BCGpostPOS = BCGpostNEG
7 Unknown NVpre > BCGpostPOS >
BCGpostNEG = NVpost > BCGpre
8 Unknown NVpost > BCGpostPOS >
BCGpostNEG > NVpre = BCGpre
9 2-dodecanone • Found in alcoholic beverages
• Found in rue, hop, and tomato leaf oils.
• Identified in feces of white-tailed deer.
• VOC produced by cattle.
NVpre > BCGpre > NVpost > BCGpostPOS >
BCGpostNEG
2-chloro-1-propanol • Used for etherification of food starch
10 Chlorate • Term includes salts of chloric acid. Natural deposits
are found in nature.
• Various microorganisms are capable of reducing
chlorate to chloride. Perchlorate reducing bacteria
utilize chlorate as a terminal electron acceptor.
• Selective inhibitor of PAPS, which is required by
HEVs in lymphoid tissues which support lymphocyte
extravasation from blood.
• Can be present in food, chlorinated water, or in some
disinfectants
BCGpostPOS = BCGpostNEG > NVpost >
BCGpre = NVpre
(Continued )
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Table 6. (Continued)
Peak Tentative Compound
Identification
Tentative Associations [32, 38, 54, 55, 58–77]85, 86 Order of Mean Peak Area Fold Difference
11 Indole • VOC produced by cattle.
• Produced by bacteria as a part of tryptophan
metabolism.
• Regulates various aspects of bacterial physiology
such as spore formation, plasmid stability, drug
resistance, biofilm formation and virulence. The
tryptophan biosynthetic pathway is integral to M.
tuberculosis survival.
NVpost > BCGpostPOS > NVpre = BCGpre =
BCGpostNEG
12 2, 6, 10,
14-tetramethylhexadecane
(phytane)
• Derivative of chlorophyll.
• Found in bovine liver, heart, muscle, fat.
• Has been described as a compound capable of
binding to CYP124, a catabolic P450 enzyme
involved in M. tuberculosis biosynthesis and
metabolism.
NVpost > BCGpostPOS >
BCGpostNEG > NVpre = BCGpre
5-hydroxylysine • Amino acid derivative of lysine found in collagenous
tissue including bovine conglutinin, a serum protein
capable of binding to immune complexes via
complement component C3bi.
• Lysine is converted to hydroxylysine in the
biosynthesis of mycobactin, a high density lipid
hexdentate iron ligand utilized by M. tuberculosis to
scavenge host non-heme iron for DNA synthesis and
respiration.
13 3, 7, 11, 15-tetramethyl-
2-hexadecene1-ol (phytol)
• Liberated from ruminant gut fermentation of plants,
converted to phytanic acid and stored in fats.
• Decomposition product of chlorophyll.
• Found in tocopherol (Vitamin E), and phylloquinone
(Vitamin K1).
• Has been observed to act as a ligand and will bind
with PKS 18 and AccD5 receptors of M. tuberculosis.
• Phytanic acid is bound by M. tuberculosis CYP124
receptors.
NVpost = BCGpostPOS > BCGpostNEG >
BCGpre > NVpre
Succinic acid (butanedoic acid) • Occurs naturally in plants, animals, soils.
• Anion (succinate) is a component of the citric acid
cycle.
• Succinate dehydrogenase (SDH) is important in
mitochondrial function (part of respiratory chain and
Krebs cycle).
• Produced by fermentation of glucose.
• Succinic acid producing bacteria have been isolated
from the rumen of cattle.
• M. tuberculosis utilizes the anion (succinate) to
sustain membrane potential, ATP synthesis, and
anaplerosis, and can remodel the tricarboxylic acid
cycle to increase production of succinate in response
to hypoxia.
• Methyl-nicotinate has been reported as a potential
biomarker for M. tuberculosis. Nicotinamide is a
compound with known tuberculocidal activity.
Metabolomics data base and literature searches were utilized to identify potential sources and associations of the VOCs identified. Sample groups are
arranged in descending order of mean peak area values to demonstrate how each VOC may be used to identify sample groups.
https://doi.org/10.1371/journal.pone.0179914.t006
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Table 7. Potential sites of origin; cellular and biofluid locations; and biofunctions of tentatively identified volatile organic compounds.
Peak Tentative Compound
Identification
Origin Cellular Location Biofluid or
Tissue
Biofunction
1 Dimethyl sulfide • Endogenous
• Microbial
• Cytoplasm • Blood
• CSF
• Feces
• Urine
• Fat
• Intestine
• Kidney
• Liver
• Osmolyte
• Enzyme cofactor
• Signaling
• Waste products
• Sulfur metabolism
3-methylthiophene
2 Benzaldehyd3 • Endogenous • Blood
• Feces
• Saliva
• Toluene degradation
Dimethyl sulfone
(methylsulfonylmethane, MSM)
• Endogenous
• Microbial
• Cytoplasm • Blood
• CSF
• Urine
• Saliva
• Osmolyte
• Enzyme cofactor
• Signaling
• Sulfur metabolism
• Waste product
• Methanethiol metabolism
3 Unknown
4 Methoxy-phenyl-oxime • Immines are common in nature. Example: Vitamin B6
promotes the deamination of amino acids via the
formation of imines
5 2-Methylpyridine (2-picoline)
6 Citrulline • Endogenous • Mitochondria • Blood
• CSF
• Saliva
• Urine
• Epidermis
• Fibroblasts
• GIT
• Kidney
• Liver
• Neural
Tissue
• Placenta
• Platelet
• Prostate
• Byproduct of Urea Cycle
• Arginine biosynthesis.
• Aspartate, alanine and proline metabolism.
• Biosynthesis of amino acids
7 Unknown
8 Unknown
9 2-dodecanone • Endogenous
• Food
• Membrane • Feces
• Saliva
• Nutrient
2-chloro-1-propanol • Endogenous
• Food
• Cytoplasm
• Extracellular
• Nutrient
10 Chlorate • Endogenous • Osmolyte
• Enzyme cofactor
• Signaling
(Continued )
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factors such as the sample (breath vs. feces); VOC collection method (sorbent tubes vs. SPME);
and differences in GCMS analysis methods may have contributed to this disparity. Five identi-
fied compounds (1H-indole, 2-methyl pyridine, benzaldehyde, dimethyl sulfide, dimethyl sul-
fone) have been associated with normal ruminant physiology in cattle [61, 81]. Dimethyl
sulfide has been previously reported in the literature as a compound associated with M. bovis
cultures [58]. Eight of our tentatively identified compounds have not been previously reported
in our prior studies or elsewhere.
We were not successful in detecting a specific candidate VOC biomarker to indicate BCG
vaccination or pathogenic M. bovis exposure/infection. Tentative biomarkers associated with
M. tuberculosis infection have been suggested [19, 58, 82, 83]; however, because of the
Table 7. (Continued)
Peak Tentative Compound
Identification
Origin Cellular Location Biofluid or
Tissue
Biofunction
11 Indole • Endogenous
• Microbial
• Membrane • Epidermis
• Feces
• Saliva
• Urine,
• Fibroblasts
• GIT
• Neural
Tissues
• Tryptophan metabolism
• Phenylalanine, tyrosine, tryptophan biosynthesis
• Protein digestion and absorption
12 2, 6, 10,
14-tetramethylhexadecane
(phytane)
5-hydroxylysine • Endogenous • Cytoplasm • Blood
• Urine
• Protein synthesis
• Amino acid biosynthesis
• Lysine degradation
13 3, 7, 11, 15-tetramethyl-
2-hexadecene1-ol (phytol)
• Food • Extracellular
• Membrane
• Fibroblasts • Nutrient
• Stabilizer
• Surfactants
• Emulsifier
• Cell signaling
• Fuel and energy storage
• Fuel or energy source
• Membrane integrity and stability
Succinic acid (butanedoic acid) • Endogenous
• Microbial
• Extracellular
• Mitochondria
• Endoplasmic
reticulum
• Peroxisome
• Blood
• CSF
• Feces
• Saliva
• Urine
• Fat
• Neural
Tissue
• Liver
• Muscle
• Pancreas
• Placenta
• Spleen
• Alanine, proline, butanoate, butyrate, C5-branched
dibasic acid, glutamate, propanoate, tyrosine,
phenylalanine, pyruvate, propanoate metabolism
• Valine, leucine, isoleucine degradation
• DNA component
• Carnitine synthesis
• Ketone body metabolism
• Mitochondrial electron transport chain
• Citrate cycle
• Glucagon signaling pathway
• Succinate dehydrogenase component
• Nicotinate and nicotinamide metabolism
Metabolomics data base and literature searches were used to identify biological sites of origin, and physiological locations and biofunctions of the tentatively
identified VOCs.
https://doi.org/10.1371/journal.pone.0179914.t007
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influence of diet, behavior, and other factors, identification of one or two compounds as spe-
cific indicators of infection by a unique pathogen is difficult. For example, methyl-nicotinate, a
compound proposed as a M. tuberculosis biomarker, can be found in the breath of smokers
[84], is used as a flavoring ingredient, and is present in coffee, various nuts, alcoholic bever-
ages, and fruits [54, 55]. Instead, we demonstrate that a suites of VOCs may be used to discrim-
inate between unique treatment groups prior and after challenge with virulent M. bovis. If the
VOCs identified in this study are associated only with non-specific host adaptive or immune
responses to pathogen presence, comparative research must be conducted exploring the suites
of VOCs produced by other infectious diseases of cattle.
Strengths of our study include analysis of samples from physically similar Holstein steers
housed in controlled environmental and husbandry conditions, and exposed to a known con-
centration of M. bovis inoculum. Weaknesses include changes in our collection and sample
analysis method which were intentional and done with the understanding that retrospective
comparison to previous results may be compromised. The small number of samples available
for analysis was unavoidable given the expense of housing large ungulates in confinement;
however; this study represents the third time we have been able to discriminate between non-
infected and M. bovis infected animals using VOCs present in breath [32] or feces [38]. Repeat-
ability infers reliability, and repeated studies will allow compilation of a library of identified
VOCs that will better define suites of VOCs appropriate for identification of disease or vacci-
nation status.
Developing a disease surveillance modality that uses a readily accessible biological sample
(feces) collected directly from domestic livestock would improve surveillance strategies by
reducing or eliminating animal handling events, decrease animal stress, allow better opportu-
nity for retesting and storage of samples, eliminate the need for specialized laboratory training,
and improve test turnaround time. Use of feces collected from environments where wildlife
reservoirs of M. bovis or other significant pathogens reside would vastly improve the ability of
wildlife managers to assess the health status of wildlife, develop wildlife management strategies
enhancing control of agriculturally important diseases, and provide public health support. The
capability to differentiate between BCG-vaccinated and non-vaccinated animals prior to and
after exposure to M. bovis would provide a crucial surveillance modality to control and eradi-
cate bovine tuberculosis in domestic animal and wildlife reservoir populations. Continued use
and refinement of our sampling method and analysis is therefore designed to lead toward
development of a portable, labor and cost efficient tool that can accurately identify non-vacci-
nated and/or vaccinated domestic and wild animals infected with M. bovis or other pathogens
of zoonotic or agricultural importance.
Supporting information
S1 Table. Study timeline from initiation of study to completion. This table documents all
diagnostic and fecal sampling time-points, age at vaccination and M. bovis challenge, and all
other procedures pertinent to the study beginning with purchase of calves through euthanasia
and necropsy.
(TIF)
S2 Table. Comparative differences in mean peak areas of sample groups. Differences in
mean peak area were calculated for dependent (pre- vs. post-challenge) and independent (vac-
cination and infection status) comparisons. A minimum fold difference < = 3.0 criteria was
used to identify suites of VOCs useful in discriminating between sample groups.
(TIF)
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S1 Fig. Response to PPDb by calves 104 days after virulent M. bovis challenge. Blue bars
indicate skin thickness (millimeters) prior to injection of PPDb. Skin thickness 72 hours post-
PPDb injection, mean, and standard deviation of measurements for non-vaccinated (NVpost)
BCG-vaccinated M. bovis positive (BCGpostPOS); and BCG-vaccinated virulent M. bovis neg-
ative calves (BCGpostNEG) are indicated by red, purple and orange bars, respectively. All
calves were classified as reactors based on standard interpretation of the CCT [42]. Mean
responses for NVpost calves were greather than those of BCGpostPOS and BCGpostNEG
calves [56].
(TIF)
S2 Fig. Responses to PPDa and PPDb by calves 104 days after virulent M. bovis challenge.
Blue bars represent changes in skin thickness (millimeters) 72 hours post-administration of
PPDa. Differences in response to PPDb 72 hours post-administration by NVpost; BCGpost-
POS; and BCGpostNEG cattle are indicated by red, purple, and orange bars, respectively. Dif-
ference in skin thickness in response to PPDa are lower than the changes noted in skin
thickness in response to PPDb in all calves. Responses to PPDb are significantly greater in
NVpost calves [56].
(TIF)
S3 Fig. XCMS analysis sample groups using 105 statistically significant ions. Sample chro-
matograms are aligned and overlaid onto the x-axis. Features with high m/z ratios are repre-
sented by the dots farthest above the x-axis. Size of circles equates to degree of fold change
(features with greatest fold change have the largest radii). Color intensity of the circles corre-
sponds to the statistical significance (p-value) of the fold change as calculated by a Welch t-test
with unequal variances (darker color = lower p-value).
(TIF)
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